PELGIFATAMAB CORIXETAN
UNII GY4SKX8MSD

Substance Identification & Data

This profile provides standardized clinical and technical data for Pelgifatamab Corixetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GY4SKX8MSD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2413858-99-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
GY4SKX8MSD
CAS Registry Number
2413858-99-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PELGIFATAMAB CORIXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11628
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pelgifatamab Corixetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PELGIFATAMAB CORIXETAN

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FOLH1 (FOLATE HYDROLASE, PROSTATE SPECIFIC MEMBRANE ANTIGEN, PSMA)), HOMO SAPIENS MONOCLONAL ANTIBODY (PELGIFATAMAB) CONJUGATED TO CHELATOR CORIXETAN
PELGIFATAMAB CORIXETAN [INN]